New Delhi, Jan. 8 -- The unfolding crisis in Venezuela draws into sharp relief a less-recognized feature of the modern global economy: the movement of expectations often matters more than that of phys... Read More
New Delhi, Jan. 8 -- US President Donald Trump has backed the Russia sanctions bill, which could raise US tariffs to at least 500% on countries that buy Russian oil. United States Republican Senator ... Read More
New Delhi, Jan. 8 -- According to Republican Senator Lindsey Graham, US President Donald Trump has backed the Russia sanctions bill, which could raise US tariffs to at least 500% on countries that buy... Read More
New Delhi, Jan. 8 -- According to Republican Senator Lindsey Graham, US President Donald Trump has backed the Russia sanctions bill, which could raise US tariffs to at least 500% on countries that buy... Read More
New Delhi, Jan. 8 -- Barcelona's Spanish Super Cup semifinal against Athletic Club kicked off with a major talking point, the decision to bench star winger Lamine Yamal. Manager Hansi Flick addressed ... Read More
New Delhi, Jan. 8 -- Former India skipper Rohit Sharma's wife Ritika Sajdeh has bought an apartment in Mumbai worth Rs.26.30 crore, a report by SquareYards said on Thursday. According to the report, ... Read More
New Delhi, Jan. 8 -- Thangamayil Jewellery share price continued its bullish momentum for the fourth consecutive session on Thursday, January 8, surging another 8.2% to a fresh all-time high of Rs.4,1... Read More
New Delhi, Jan. 8 -- India's debt recovery regulations are poised for another set of reforms. In the upcoming budget, the Centre may announce plans to amend rules governing debt identification and re... Read More
New Delhi, Jan. 8 -- India's urbanisation and housing demand have turned wiring from an invisible commodity into a more considered choice for sustainable, safe homes. As buildings get denser and elect... Read More
New Delhi, Jan. 8 -- Panacea Bio's share price surged as much as 6% to Rs.407.60 apiece in Thursday's trading session after the company said it has completed enrolment for the Phase III clinical trial... Read More